Concepedia

Mark Kirschbaum

MK

47

Publications

8.4K

Citations

29

H-Index

1998

Active since

Affiliations

City Of Hope National Medical Center(Current)

City of Hope

National Cancer Institute

Peter MacCallum Cancer Centre

The University of Texas MD Anderson Cancer Center

Mark Kirschbaum is an author at City Of Hope National Medical Center specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

1998–2019

47

Publications

47

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, E Naparstek et al. · Blood · 1998 · 1.9K citations · Full text

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, E Naparstek et al. · Blood · 1998 · 1.8K citations

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Richard Piekarz, Robin Frye, Maria L. Turner et al. · Journal of Clinical Oncology · 2009 · 728 citations · Full text

, , +18

Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors

Leah N. Klapper, Mark Kirschbaum, Michael Seta et al. · Advances in cancer research · 1999 · 546 citations

, , +9

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

Richard Piekarz, Robin Frye, H. Miles Prince et al. · Blood · 2011 · 476 citations · Full text

Rows per page

1–5 of 47